ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 701

Variability in ICAP (International Consensus on ANA Patterns) Pattern Reporting in Testing for Antinuclear Antibodies (ANA) By Indirect Immunofluorescence Assay (IFA)

Stanley J. Naides1, Jonathan Genzen2, Gyorgy Abel3, Christine Bashleben4 and Mohammad Qasim Ansari5, 1Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, 2ARUP Laboratories Inc, Salt Lake City, UT, 3Department of Pathology and Laboratory Medicine, Lahey Clinic Burlington, Burlington, VT, 4College of American Pathologists, Northfield, IL, 5Department of Pathology and Laboratory Medicine, Louis Stokes VAMC, Cleveland, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: ANA and Diagnostic Tests

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: ANA IFA pattern may guide clinical evaluation by directing specific antibody testing. ICAP has defined consensus ANA IFA patterns and the level of competency required to identify and interpret them. This study was performed to determine laboratory practices in interpreting and reporting ANA IFA patterns.

Methods: Supplemental questions were sent to laboratories participating in the College of American Pathologist’s proficiency testing program for ANA as part of the Special Immunology S-A Survey 2016 to determine the practice of ANA testing. Of 5847 kits distributed, 1206 (21%) responded to the questionnaire; 942 were in the United States and 264 were international.

Results: Of 638 performing ANA by IFA and reporting a pattern, nearly 100% reported nucleolar, 99% homogeneous and speckled, and 96% centromere, all competent-level ICAP patterns. Only 42% reported nuclear dots (competent-level). 53% reporting nucleolar pattern further described expert-level subpatterns. Of 519 reporting speckled patterns, only 29% reported dense fine speckles, a competent-level pattern reportedly found in normals. “Other” speckled was reported by 44%. 4% did not report speckled pattern at all. Of those reporting nuclear dots, 86% differentiated many nuclear dots and 84% few nuclear dots. Nuclear envelope (expert-level) was reported by 18%. Competent-level cytoplasmic patterns were reported: golgi 69%, mitochondrial 65%, speckles 30%, 17% rods and rings, reticular 12% and polar 10%. Expert-level cytoplasmic patterns were reported: spindle apparatus 59%, centriole 55%, mid body 45%, and lysosomal 32%. Only 54% used an internal fluorescence intensity standard.

Conclusion: Pattern reporting practice is variable. Cytoplasmic pattern reporting is limited, possibly reflecting a lack of consensus that cytoplasmic patterns should be reported in an “antinuclear” antibody test. Failure to use an internal fluorescence intensity standard by nearly half of the laboratories may increase inter-assay and inter-observer variation in the threshold for staining positivity and in titer determination.


Disclosure: S. J. Naides, Quest Diagnostics, 3; J. Genzen, None; G. Abel, None; C. Bashleben, None; M. Q. Ansari, None.

To cite this abstract in AMA style:

Naides SJ, Genzen J, Abel G, Bashleben C, Ansari MQ. Variability in ICAP (International Consensus on ANA Patterns) Pattern Reporting in Testing for Antinuclear Antibodies (ANA) By Indirect Immunofluorescence Assay (IFA) [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/variability-in-icap-international-consensus-on-ana-patterns-pattern-reporting-in-testing-for-antinuclear-antibodies-ana-by-indirect-immunofluorescence-assay-ifa/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variability-in-icap-international-consensus-on-ana-patterns-pattern-reporting-in-testing-for-antinuclear-antibodies-ana-by-indirect-immunofluorescence-assay-ifa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology